Compile Data Set for Download or QSAR
Report error Found 39 Enz. Inhib. hit(s) with all data for entry = 13079
LigandPNGBDBM756794(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  0.320nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756798(4-(((6-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazo...)
Affinity DataKi:  0.540nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756788(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  0.600nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756804(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  0.770nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756797(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  0.910nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756816(3-(5-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  0.990nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756815(7-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  0.990nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756678(US20250215016, Compound 1)
Affinity DataKi:  1.20nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756809(4-(((6-(5,6-dihydroimidazo [1,2-a]pyrazin-7(8H)- y...)
Affinity DataKi:  1.44nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756795(3-(5-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  1.62nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756784(US20250215016, Compound 3)
Affinity DataKi:  1.66nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756786(US20250215016, Compound 7)
Affinity DataKi:  2.14nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756812((3S,11aR)-7-(6-((3-(4-fluorophenyl)-5-methylisoxaz...)
Affinity DataKi:  2.24nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756808(3-(4-fluorophenyl)-5-methyl- 4-(((6-(3-methyl-5,6-...)
Affinity DataKi:  2.44nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756791(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  2.5nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756793(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  2.59nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756789(3-(5-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  2.60nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756799(4-(((5-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazo...)
Affinity DataKi:  3.06nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756817(3-(4-fluorophenyl)- 5-methyl-4-(((5-(2-methyl- 5,6...)
Affinity DataKi:  3.09nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756787(US20250215016, Compound 10)
Affinity DataKi:  3.20nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756810(7-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  3.39nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756819((S)-8-[6-((3-(4-fluorophenyl)- 5-methylisoxazol- 4...)
Affinity DataKi:  3.84nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756802(3-(4-fluorophenyl)-5-methyl-4-((5- (3-methyl-5,6-d...)
Affinity DataKi:  3.90nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756806(3-(4-fluorophenyl)-5-methyl-4-(((5-(5,6,7,8- tetra...)
Affinity DataKi:  4.93nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756811(7-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  5.37nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756813(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  6.31nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756800(3-(5-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  6.75nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756792(3-(4-fluorophenyl)-5-methyl-4-((5-(7-methyl- 5,6,7...)
Affinity DataKi:  6.93nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756783(US20250215016, Compound 2)
Affinity DataKi:  7.70nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756820(1-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  8.63nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756807(3-(5-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  9.74nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756805(1-(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol- 4-y...)
Affinity DataKi:  9.86nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756796(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  11.2nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756790(7-ethyl-3-(6-((3-(4-fluorophenyl)-5-methylisoxazol...)
Affinity DataKi:  12.5nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756814((S)-8-(5-((3-(4-fluorophenyl)- 5-methylisoxazol- 4...)
Affinity DataKi:  21.8nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756801(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  22.1nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756803(3-(6-((3-(4-fluorophenyl)-5-methylisoxazol-4-yl) m...)
Affinity DataKi:  33nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756818(4-(((5-(5,6-dihydroimidazo [1,2-a]pyrazin-7(8H)-yl...)
Affinity DataKi:  68.5nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM756785(US20250215016, Compound 6)
Affinity DataKi:  103nMAssay Description:The assay was carried out in a 200 μL system (96-well plate from Agilent) with 100 μL of cell membrane. The concentration of 3H-flunitazepam (from Pe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent